#CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), & #ARDS (type2) with different pathophysiology & clinical implications #FOAMed #FOAMcc #ICU #IntensiveCare #pneumonia #PEEP #TC @ISICEM @jlvincen @gattinon https://t.co/z6SvhwoGsx
COVID-19 pneumonia: ARDS or not?
Mentions
Extended reach
Total likes
Video views
Mentions per month
Apr 2020 – Nov 2023Where it's discussed
-
X / Twitter157 posts
-
Facebook8 posts
-
News5 articles
-
YouTube3 videos
-
Blogs3 articles
-
Reddit2 posts
AI synopsis
What people are saying
The discussions frequently reference the breakdown of COVID-19 patients into two types as outlined by Gattinoni, which has prompted multiple users to weigh in on treatment approaches and potential interventions. Phrases like 'early treatment is crucial' highlight the urgency and underscore the article's perceived influence, while remarks about distinguishing between ARDS and non-ARDS cases showcase a desire for clarity in clinical practice.
Many discussions express support for the points raised in the article, particularly regarding the classification of COVID-19 pneumonia cases.
There is a high level of curiosity throughout the discussions, as users actively engage with the topic, asking questions and referencing the publication.
While some posts show surface-level engagement, others dive deeper into clinical implications and treatment approaches related to ARDS and COVID-19.
Several users indicate that the research could significantly influence clinical practices and how COVID-19 pneumonia is understood and treated.
Abstract in brief
- COVID-19 can lead to pneumonia in some patients, which may cause severe respiratory issues.
- Acute Respiratory Distress Syndrome (ARDS) is a serious complication that can arise from COVID-19 pneumonia.
- Understanding whether COVID-19 pneumonia progresses to ARDS is crucial for effective treatment and management of affected individuals.
Top posts
Most liked on X and Bluesky@PaulRiz504 @BigBadUSNDawg @ArmandDoma Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020). Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. Gattinoni, L., Chiumello, D., & Rossi, S. (2020). COVID-19 pneumonia: ARDS or not? Critical
Este editorial de @gattinon es un "must read" en tiempos de #COVID19 Sustenta lo que mencionaba en el hilo de hace unos días. https://t.co/jxjdsvFTdt https://t.co/ZPIsyTL2wI
references : https://t.co/Q3dZmLGESm https://t.co/BPiVCjAelf https://t.co/axcL9aElXY
ARDSを伴わないCOVID-19患者の管理 ・肺コンプライアンスが良好な患者ではPEEPは低めで! ・1回換気量は6ml/kgに制限しなくて良い ・呼吸回数は20を超えるべきではない ・患者は安静にさせるのがどんな高コストの介入よりも良い https://t.co/kOctFvBaHd
ARDSを伴うCOVID-19患者の管理 重症ARDS患者に対して行う普通の治療を行う ・低一回換気量 ・腹臥位療法 ・比較的高めのPEEP) 重症低酸素でも腹臥位がどの症例にも効果的であるわけではないということでした。 https://t.co/kOctFvBaHd
All mentions
COVID-19 Critical Care Management Guidelines Based on Evidence
These guidelines, developed by 36 international experts, provide evidence-based recommendations for managing critically ill COVID-19 patients in the ICU, focusing on infection control, diagnosis, support, and treatment…
Understanding COVID-19 Pneumonia and ARDS Progression
COVID-19 can lead to pneumonia in some patients, which may cause severe respiratory issues. This video explores the critical relationship between COVID-19 pneumonia and the development of Acute Respiratory Distress…
Understanding COVID-19 Pneumonia and ARDS Risk Factors
COVID-19 can lead to pneumonia, potentially resulting in severe respiratory issues. Understanding the progression of COVID-19 pneumonia to Acute Respiratory Distress Syndrome (ARDS) is crucial for effective treatment…
@PaulRiz504 @BigBadUSNDawg @ArmandDoma Arentz, M., Yim, E., Klaff, L., Lokhandwala, S., Riedo, F. X., Chong, M., & Lee, M. (2020). Characteristics and Outcomes of 21 Critically Ill Patients With COVID-19 in Washington State. Gattinoni, L., Chiumello, D., & Rossi, S. (2020). COVID-19 pneumonia: ARDS or not? Critical
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @qrPovpz8L33YIcW: @ascensiontvjp コロナ肺炎の病態は複雑なようですね。 Covid-19 pneumoniaでやると、イロンナ画像ご出てきました
@ascensiontvjp コロナ肺炎の病態は複雑なようですね。 Covid-19 pneumoniaでやると、イロンナ画像ご出てきました
RT @ApicsOfficial: Inventor of ECCO2R and promoter of the “baby lung”, Prof Luciano Gattinoni @gattinon is a familiar face to many. Check o…
RT @ApicsOfficial: Inventor of ECCO2R and promoter of the “baby lung”, Prof Luciano Gattinoni @gattinon is a familiar face to many. Check o…
Inventor of ECCO2R and promoter of the “baby lung”, Prof Luciano Gattinoni @gattinon is a familiar face to many. Check out his recent paper on COVID-19 Pneumonia: ARDS or not? and be sure to catch him speaking on Ventilatory Mx on Track 10 during APICS! https://t.co/6EQR9uLeMt
@load_dependent @pseudo_sapiens @deralteGaukler @GermHunterMD @LancetRespirMed @progdoctalk @JAMANetwork @radboudumc @gattinon Prof Gattinoni claims that it is: C 'COVID-19 pneumonia: ARDS or not?' https://t.co/Yiy3WJ0Zfh I agree with you Lars that these are debatable points. Covid-19 is such a new disease that no one knows exactly what's really going on.
@cofrandi @PedsICU_tweets Another https://t.co/cB5LzzbRv0 https://t.co/FdEZr4SLeq
RT @drdiegocosta: @EzequielZaidel Hay mucha discusión sobre el tema de ventilación en COVID-19. Me gustó mucho el artículo de Gattinoni: ht…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @FatmaMag: references : https://t.co/Q3dZmLGESm https://t.co/BPiVCjAelf https://t.co/axcL9aElXY
RT @BebetoDice: @OrlandoRPN @Smester07 Gattinoni los dividió en dos grupos https://t.co/J3yo6BL1Lv
@lissasauras @RoundRockTim This is more to my point https://t.co/0XenzqIPfG
@SwiftRead Those metrics are not stand-alone. They overlap. Apart from the math, the ICD-10 code definitions tell you that those two categories overlap. The ICODs for most covid19 deaths are ARDS/hypoxemia. For some others it is pneumonia, viral or secondary. https://t.co/5AugrzCLaw
Is COVID-19 Pneumonia ARDS or Not? https://t.co/sENCJZcYNp via @ICU_Management
RT @doctor_finesse: COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/PPdYyjvYYm
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/PPdYyjvYYm
references : https://t.co/Q3dZmLGESm https://t.co/BPiVCjAelf https://t.co/axcL9aElXY
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @pharmaciensAPES: 2 types de patients COVID selon la présentation clinique? https://t.co/PGUbgSVh2i https://t.co/WsXOjmsnWU
2 types de patients COVID selon la présentation clinique? https://t.co/PGUbgSVh2i https://t.co/WsXOjmsnWU
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
@TheNYCBMX @aravosis https://t.co/RJj364ST3g
@MuschiLambi @DianaEspir @RocksRoxana @TomiLahren @tekwendell @BasedPoland There is a new clinical trial that will take place in japan using Ibudilast, so this should be considered along with it https://t.co/6iYAgqs5ww
@ScottGottliebMD @JoeSquawk @outbreakIn2020 @ErniesAirport @BeckyQuick @andrewrsorkin @SquawkCNBC https://t.co/1OssXKqw1x
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @renalpages: 2 types of lung involvement in COVID19 pneumonia Type 1 Near normal pulmonary compliance with isolated viral pneumonia t…
@EzequielZaidel Hay mucha discusión sobre el tema de ventilación en COVID-19. Me gustó mucho el artículo de Gattinoni: https://t.co/JdPoUqUFjf
2 types of lung involvement in COVID19 pneumonia Type 1 Near normal pulmonary compliance with isolated viral pneumonia type 2 -Decreased pulmonary compliance https://t.co/4f1tIuyX1X Prone ventilation sometimes helpful Fluid balance not easy – even in the ICU https://t.co/bZ06eObSt5
@KerrPuter @mgyory @ewarren Covid19 is the reason the percentage of deaths due to pneumonia is spiking. Covid19 pneumonia is killing a lot of people. https://t.co/5AugrzCLaw
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @ICU_Management: Is #COVID19 Pneumonia ARDS or Not? Could there be subtypes? https://t.co/mYt72FAP5Y
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
@business See Dr. Cameron Kyle-Sidell @cameronks who questions the current ventilator protocols: Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumonia: ARDS or not?
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
https://t.co/eLXfaC0P9W
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
tiens, enfin des mecs qui réfléchissent: https://t.co/AYpilNMb5E
RT @richardursomd: Late treatment still a big unknown. Treat early!! COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t…
#Covid19 https://t.co/fkCySZsduW
ARDSを伴うCOVID-19患者の管理 重症ARDS患者に対して行う普通の治療を行う ・低一回換気量 ・腹臥位療法 ・比較的高めのPEEP) 重症低酸素でも腹臥位がどの症例にも効果的であるわけではないということでした。 https://t.co/kOctFvBaHd
ARDSを伴わないCOVID-19患者の管理 ・肺コンプライアンスが良好な患者ではPEEPは低めで! ・1回換気量は6ml/kgに制限しなくて良い ・呼吸回数は20を超えるべきではない ・患者は安静にさせるのがどんな高コストの介入よりも良い https://t.co/kOctFvBaHd
RT @MDEmergencias: COVID-19 pneumonia: ARDS or not?... By Gattinoni, Chiumello and Rossi https://t.co/QWvuBfnJeX
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/8IdJTpSs17
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Infermiere_line: COVID-19 pneumonia: #ARDS or not? @Crit_Care | #ECM https://t.co/7AeOwVZDL4
COVID-19 pneumonia: #ARDS or not? @Crit_Care | #ECM https://t.co/7AeOwVZDL4
COVID-19 pneumonia: #ARDS or not? @Crit_Care | #ECM https://t.co/OEivtAvAXy
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/8IdJTpSs17
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @ICU_Management: Is #COVID19 Pneumonia ARDS or Not? Could there be subtypes? https://t.co/mYt72FAP5Y
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1),…
#CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al. 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), & #ARDS (type2) with different pathophysiology & clinical implications #FOAMed #FOAMcc #ICU #IntensiveCare #pneumonia #PEEP #TC @ISICEM @jlvincen @gattinon https://t.co/z6SvhwoGsx
COVID-19 pneumonia: ARDS or not? Type 1: Near normal pulmonary compliance with isolated viral pneumonia Type 2: Decreased pulmonary compliance https://t.co/Dmt1GSOJp1 https://t.co/oDptPSQx2f
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
@OrlandoRPN @Smester07 Gattinoni los dividió en dos grupos https://t.co/J3yo6BL1Lv
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @kazuki24_: Gattinoni医師のCOVID-19の2つのtypeの話。軽症例のtypeはコンプライアンス正常であり、V/Q mismatchが低酸素の原因?吸気努力が強く自己による肺障害をきたしそうなものは早期に挿管し重症化予防を。一方、重症例はいわゆるA…
RT @Crit_Care: #CritCare #OA https://t.co/vh4xwCMeRH #Gattinoni et al 2 types of #COVID19 patients are distinguishable: non-ARDS (type1), &…
https://t.co/Bsix1vrAEH COVID-19: ARDS or not ARDS?
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @richardursomd: Late treatment still a big unknown. Treat early!! COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t…
Late treatment still a big unknown. Treat early!! COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/nXyrdYKvRf
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
Reposted from @ccsalud_ing_hum Reposted from critical_care_updates "COVID-19 pneumonia: ARDS or not?" Published: 16th April 2020 Type 1 versus type 2 patients. Limiting PEEP levels? Have… https://t.co/FlpvfmnVXr
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @ICU_Management: Is #COVID19 Pneumonia ARDS or Not? Could there be subtypes? https://t.co/mYt72FAP5Y
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @ICU_Management: Is #COVID19 Pneumonia ARDS or Not? Could there be subtypes? https://t.co/mYt72FAP5Y
COVID-19 pneumonia: ARDS or not? | Critical Care | Full Text https://t.co/PORA5uVJcG
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
RT @cameronks: Very important! Published April 16 by Italian world renowned ARDS researcher and physician Dr. Gattinoni: COVID-19 pneumon…
Este editorial de @gattinon es un "must read" en tiempos de #COVID19 Sustenta lo que mencionaba en el hilo de hace unos días. https://t.co/jxjdsvFTdt https://t.co/ZPIsyTL2wI